SI-BONE Q1 revenue up 25% to $47.3M, posts positive adjusted EBITDA, raises FY guidance

SI-BONE, Inc.

2025-Q1 EPS reported -$0.15 revenue$47,290,000

Worldwide revenue $47.3M, up 24.9% YoY; U.S. revenue $44.8M, up 26.6%.
Gross margin 79.7% vs 78.9% a year ago; net loss improved 40% to $6.5M ($0.15/share).
Adjusted EBITDA positive $0.5M vs loss of $4.0M in Q1 2024; cash $144.4M, net cash usage down 31.7%.
FY2025 revenue guidance raised to $193.5M-$197.5M (prior $193.5M-$195.5M); expects positive adjusted EBITDA for full year.
Added 300 active U.S. physicians in Q1; CMS proposed NTAP for iFuse TORQ TNT up to $3,960/ procedure.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.